Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.46 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.43 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23857928 | 1.00 | FOLH1 (0.51) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL31520392 | 1.00 | FOLH1 (0.51) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL29642982 | 1.00 | FOLH1 (0.51) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL30307570 | 1.00 | FOLH1 (0.51) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL30307583 | 1.00 | FOLH1 (0.51) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL31679371 | 0.98 | FOLH1 (0.50) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL31520388 | 0.98 | FOLH1 (0.50) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL30705346 | 0.97 | FOLH1 (0.49) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL9442199 | 0.97 | FOLH1 (0.54) | FOLH1GSRCPB2SLC15A2FNTA | |
| SCHEMBL9442197 | 0.97 | FOLH1 (0.54) | FOLH1GSRCPB2SLC15A2FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11938191-B2 | Block copolymers | GENEVANT SCIENCES GMBH (CH) | 2024-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11938191-B2 | Block copolymers | CHMP4B, CD47, EEA1 | FOLH1 1401/4885GSR 2360/4885CPB2 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.